Title 40

PART 799 SUBPART H

Subpart H - Health Effects Test Guidelines Source:62 FR 43824, Aug. 15, 1997, unless otherwise noted.

40:35.0.1.1.8.7.1.1SECTION 799.9110
   799.9110 TSCA acute oral toxicity.
40:35.0.1.1.8.7.1.2SECTION 799.9120
   799.9120 TSCA acute dermal toxicity.
40:35.0.1.1.8.7.1.3SECTION 799.9130
   799.9130 TSCA acute inhalation toxicity.
40:35.0.1.1.8.7.1.4SECTION 799.9135
   799.9135 TSCA acute inhalation toxicity with histopathology.
40:35.0.1.1.8.7.1.5SECTION 799.9305
   799.9305 TSCA Repeated dose 28-day oral toxicity study in rodents.
40:35.0.1.1.8.7.1.6SECTION 799.9310
   799.9310 TSCA 90-day oral toxicity in rodents.
40:35.0.1.1.8.7.1.7SECTION 799.9325
   799.9325 TSCA 90-day dermal toxicity.
40:35.0.1.1.8.7.1.8SECTION 799.9346
   799.9346 TSCA 90-day inhalation toxicity.
40:35.0.1.1.8.7.1.9SECTION 799.9355
   799.9355 TSCA reproduction/developmental toxicity screening test.
40:35.0.1.1.8.7.1.10SECTION 799.9365
   799.9365 TSCA combined repeated dose toxicity study with the reproduction/developmental toxicity screening test.
40:35.0.1.1.8.7.1.11SECTION 799.9370
   799.9370 TSCA prenatal developmental toxicity.
40:35.0.1.1.8.7.1.12SECTION 799.9380
   799.9380 TSCA reproduction and fertility effects.
40:35.0.1.1.8.7.1.13SECTION 799.9410
   799.9410 TSCA chronic toxicity.
40:35.0.1.1.8.7.1.14SECTION 799.9420
   799.9420 TSCA carcinogenicity.
40:35.0.1.1.8.7.1.15SECTION 799.9430
   799.9430 TSCA combined chronic toxicity/carcinogenicity.
40:35.0.1.1.8.7.1.16SECTION 799.9510
   799.9510 TSCA bacterial reverse mutation test.
40:35.0.1.1.8.7.1.17SECTION 799.9530
   799.9530 TSCA in vitro mammalian cell gene mutation test.
40:35.0.1.1.8.7.1.18SECTION 799.9537
   799.9537 TSCA in vitro mammalian chromosome aberration test.
40:35.0.1.1.8.7.1.19SECTION 799.9538
   799.9538 TSCA mammalian bone marrow chromosomal aberration test.
40:35.0.1.1.8.7.1.20SECTION 799.9539
   799.9539 TSCA mammalian erythrocyte micronucleus test.
40:35.0.1.1.8.7.1.21SECTION 799.9620
   799.9620 TSCA neurotoxicity screening battery.
40:35.0.1.1.8.7.1.22SECTION 799.9630
   799.9630 TSCA developmental neurotoxicity.
40:35.0.1.1.8.7.1.23SECTION 799.9748
   799.9748 TSCA metabolism and pharmacokinetics
40:35.0.1.1.8.7.1.24SECTION 799.9780
   799.9780 TSCA immunotoxicity.